Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Affimed Announced Updated Data On Its Lead Innate Cell Engager Acimtamig In Combination With Allogeneic NK In Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy And Are Double-refractory To Brentuximab Vedotin And Checkpoint Inhibitors

Author: Benzinga Newsdesk | December 11, 2023 07:02am

Posted In: AFMD